dr. william gradishar on the importance of enriching clinical trials
Published 11 years ago • 68 plays • Length 0:47Download video MP4
Download video MP3
Similar videos
-
1:38
dr. william gradishar discusses the eribulin and capecitabine 301 study
-
1:02
dr. gradishar discusses the results of the bolero-1 trial
-
1:59
william j. gradishar, md
-
1:22
dr. william gradishar discusses 10 years of adjuvant tamoxifen
-
2:55
her2 biosimilars in clinical practice - an interview with dr. william gradishar
-
3:56
early ms symptoms. first signs of ms. information you need to know.
-
5:33
cancer immune checkpoint inhibitors
-
58:21
rumc gobeyond : keynote speaker series 2021 (preventing diabetes)
-
2:41
richard fisher, m.d. speaks about the significance of the spore grant
-
0:51
dr. goetz on treatment of metastatic hr breast cancer
-
0:47
the importance of the ms prodrome in early diagnosis
-
0:18
copy of dr. goetz on treatment of metastatic hr breast cancer
-
1:48
geoffrey orme, do | intermountain health
-
2:32
dr. goetz on treatment challenges for esr1-mutant breast cancer
-
0:47
dr. hamilton on the addition of biosimilars to breast oncology
-
1:23
prognostic value of baseline snfl on treatment effect of evobrutinib
-
19:51
from brain to liver: advances in wilson disease management
-
0:58
trailer: the government is your doctor now — leading pathologist speaks out
-
4:25
radgrad supervisor: dr. william prestwich
-
2:12
promedica physicians: william gray, md
-
1:30
brain tumors & immune-checkpoint inhibitors
-
1:15
uf health neurosurgery radiosurgery